Sisram Medical, an Israel incorporated global provider of energy-based medical aesthetic treatment systems incorporated, has placed a maximum of 24 million shares at HK$25.90 per share, the bottom end of the HK$25.90 to HK$26.90 marketing range. Aggregate gross proceeds for the subsidiary of Chinese multinational conglomerate, Fosun International, are approximately HK$622m (US$80m). The placement, representing…
Home Healthcare Markets International Business Hong Kong: Sisram Medical places 24 million shares to raise HK$622m